AVNS vs. ASTH
AVNS (Avanos Medical, Inc.) and ASTH (Astrana Health Inc) are both stocks. Both are in the Healthcare sector — AVNS in Medical Devices, ASTH in Medical Care Facilities. Over the past 10 years, AVNS returned -3.20%/yr vs 23.67%/yr for ASTH. Their 0.25 correlation means their historical movements had little consistent relationship.
Performance
AVNS vs. ASTH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVNS achieves a 122.53% return, which is significantly higher than ASTH's 43.33% return. Over the past 10 years, AVNS has underperformed ASTH with an annualized return of -3.20%, while ASTH has yielded a comparatively higher 23.67% annualized return.
AVNS
- 1D
- 0.00%
- 1M
- 0.24%
- 6M
- 87.61%
- YTD
- 122.53%
- 1Y
- 127.60%
- 3Y*
- 0.81%
- 5Y*
- -8.02%
- 10Y*
- -3.20%
- ALL TIME*
- -2.29%
ASTH
- 1D
- -3.05%
- 1M
- -27.68%
- 6M
- 56.38%
- YTD
- 43.33%
- 1Y
- 64.86%
- 3Y*
- -1.27%
- 5Y*
- -16.65%
- 10Y*
- 23.67%
- ALL TIME*
- 39.45%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $22.80M | $25.37M | $25.10M | |
| $16.42M | $17.44M | $26.62M |
AVNS vs. ASTH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AVNS Avanos Medical, Inc. | 122.53% | -29.46% | -29.02% | -17.11% | -21.95% | -24.43% | 36.14% | -24.76% | -3.01% | 24.88% |
ASTH Astrana Health Inc | 43.33% | -21.31% | -17.68% | 29.44% | -59.73% | 302.19% | -0.76% | -7.25% | -17.29% | 220.00% |
Correlation
The correlation between AVNS and ASTH is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.34 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.37 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.28 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2014 | 0.25 |
The correlation between AVNS and ASTH shifts across timeframes, from 0.21 (1 year) to 0.37 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
AVNS:
$1.17B
ASTH:
$1.76B
AVNS:
-$2.24
ASTH:
$0.61
AVNS:
1.08
ASTH:
0.50
AVNS:
$715.90M
ASTH:
$3.53B
AVNS:
$353.40M
ASTH:
$238.21M
AVNS:
-$29.60M
ASTH:
$125.28M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVNS vs. ASTH — Risk / Return Rank
AVNS
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ASTH
AVNS vs. ASTH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Avanos Medical, Inc. (AVNS) and Astrana Health Inc (ASTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVNS | ASTH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.74 | ||
| Sortino ratioReturn per unit of downside risk | +2.59 | ||
| Omega ratioGain probability vs. loss probability | 1.62 | 1.21 | +0.41 |
| Calmar ratioReturn relative to maximum drawdown | 6.61 | 1.06 | +5.55 |
| Martin ratioReturn relative to average drawdown | 14.84 | 2.34 | +12.49 |
Loading charts...
Drawdowns
AVNS vs. ASTH - Drawdown Comparison
The maximum AVNS drawdown since its inception was -86.39%, roughly equal to the maximum ASTH drawdown of -84.80%. Use the drawdown chart below to compare losses from any high point for AVNS and ASTH.
Loading charts...
Drawdown Indicators
| AVNS | ASTH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.39% | -84.80% | -1.59% |
Max Drawdown (1Y)Largest decline over 1 year | -16.19% | -46.41% | +30.22% |
Max Drawdown (3Y)Largest decline over 3 years | -59.94% | -70.96% | +11.02% |
Max Drawdown (5Y)Largest decline over 5 years | -72.54% | -84.80% | +12.26% |
Max Drawdown (10Y)Largest decline over 10 years | -86.39% | -84.80% | -1.59% |
Current DrawdownCurrent decline from peak | -65.60% | -70.23% | +4.63% |
Average DrawdownAverage peak-to-trough decline | -47.25% | -47.26% | +0.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.44% | 21.02% | -13.58% |
Volatility
AVNS vs. ASTH - Volatility Comparison
The current volatility for Avanos Medical, Inc. (AVNS) is 1.66%, while Astrana Health Inc (ASTH) has a volatility of 12.61%. This indicates that AVNS experiences smaller price fluctuations and is considered to be less risky than ASTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVNS | ASTH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.66% | 12.61% | -10.95% |
Volatility (6M)Calculated over the trailing 6-month period | 55.78% | 42.54% | +13.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.12% | 72.83% | +4.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.85% | 62.15% | -14.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.55% | 91.31% | -46.76% |
Dividends
AVNS vs. ASTH - Dividend Comparison
Neither AVNS nor ASTH has paid dividends to shareholders.
Financials
AVNS vs. ASTH - Financials Comparison
This section allows you to compare key financial metrics between Avanos Medical, Inc. and Astrana Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVNS vs. ASTH - Profitability Comparison
AVNS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported a gross profit of 94.20M and revenue of 182.20M. Therefore, the gross margin over that period was 51.7%.
ASTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported a gross profit of 0.00 and revenue of 965.10M. Therefore, the gross margin over that period was 0.0%.
AVNS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported an operating income of 8.90M and revenue of 182.20M, resulting in an operating margin of 4.9%.
ASTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported an operating income of 28.53M and revenue of 965.10M, resulting in an operating margin of 3.0%.
AVNS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Avanos Medical, Inc. reported a net income of 5.10M and revenue of 182.20M, resulting in a net margin of 2.8%.
ASTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Astrana Health Inc reported a net income of 14.44M and revenue of 965.10M, resulting in a net margin of 1.5%.
Frequently Asked Questions
AVNS and ASTH have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASTH has higher volatility (12.61%) compared to AVNS (1.66%). In terms of maximum drawdown, AVNS dropped -86.39% vs ASTH's -84.80%.
AVNS currently has the higher Sharpe Ratio (1.42 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVNS and ASTH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer